Sort
39,280 grants matching “leukemia”
p38 MAP kinase in early thymocyte development
$368,763Mercedes R. Rincon · University Of Vermont & St Agric College · R01 · FY2011 · AI
p38 MAP kinase in early thymocyte development
$368,763Mercedes R. Rincon · University Of Vermont & St Agric College · R01 · FY2012 · AI
Exploiting dual-TCR for rescue of CD8 T cell tolerance in adoptive immunotherapy
$368,750Ryan M Teague · Saint Louis University · R01 · FY2010 · AI
Endothelial lineage specification and differentiation in vertebrate embryos
$368,750Suk-Won Jin · Univ Of North Carolina Chapel Hill · R01 · FY2008 · HL
Genetic Dissection of Drosophila Hematopoiesis
$368,746University Of California Los Angeles · R01 · FY2002 · HL
Mitochondrial determination of response to targeted AML therapies
$368,732Anthony G Letai · Brigham And Women'S Hospital · P01 · FY2015 · CA
CELLULAR TRANSDUCTION FOR DRUG DELIVERY IN CANCER
$368,696University Of Southern California · P01 · FY2000 · CA
Molecular and cellular mechanisms of the actin cytoskeleton organization and function
$368,641Dmitri Kudryashov · Ohio State University · R01 · FY2022 · GM
Signal-dependent Phosphorylation and Function of IKKy
$368,629Dean Ballard · Vanderbilt University · R01 · FY2006 · AI
The Role of ATM in Suppression of Lymphomas
$368,600Shan Zha · Columbia University Health Sciences · R01 · FY2019 · CA
Exploring persistent epigenetic changes after prenatal famine exposure in humans
$368,585L H Lumey · Columbia University Health Sciences · RC1 · FY2009 · HD
ARID5B and disparities of childhood leukemia
$368,510Jun J. Yang · St. Jude Children'S Research Hospital · U01 · FY2017 · CA
ARID5B and disparities of childhood leukemia
$368,510Jun J. Yang · St. Jude Children'S Research Hospital · U01 · FY2018 · CA
Metabolic mechanisms of venetoclax resistance in acute myeloid leukemia stem cells
$368,502Craig T. Jordan · University Of Colorado Denver · R01 · FY2020 · CA
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
$368,487Yong Lu · Methodist Hospital Research Institute · R37 · FY2022 · CA
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation
$368,485Adrienne M. Dorrance · Ohio State University · R01 · FY2022 · CA
DC-ASGPR AS A NOVEL TARGET FOR CONTROLLING GVHD AND ALLOGRAFT REJECTION
$368,480Sangkon Oh · Baylor Research Institute · R56 · FY2013 · AI
STUDIES ON VITAMIN D AND CALCIUM METABOLISM
$368,417University Of California Riverside · R01 · FY2005 · DK
Molecular characterization of Acute Myeloid Leukemia
$368,389Irving Lerner Weissman · Stanford University · R01 · FY2007 · CA
Regulation of Human Embryonic Stem Cell Self-Renewal
$368,377C. Anthony Blau · University Of Washington · P01 · FY2008 · GM
Molecular genetics of MLL-associated leukemia
$368,361Manuel O Diaz · Loyola University Chicago · P01 · FY2009 · CA
Molecular Characterization of Acute Myeloid Leukemia
$368,319Irving Lerner Weissman · Stanford University · R01 · FY2013 · CA
Genetic Etiology of Agammaglobulinemia with Absent B Cells
$368,298Mary Ellen Conley · Rockefeller University · R01 · FY2015 · AI
Chaetocin as a Potential Therapy for Multiple Myeloma
$368,294Keith C Bible · Mayo Clinic Rochester · R01 · FY2010 · CA
Role of KLHL6 inactivation in mature B-cell malignancies
$368,288Luca Busino · University Of Pennsylvania · R01 · FY2018 · CA